OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation
Peng Chen, Xuejie Li, Ruonan Zhang, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 5107-5119
Open Access | Times Cited: 305
Peng Chen, Xuejie Li, Ruonan Zhang, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 5107-5119
Open Access | Times Cited: 305
Showing 1-25 of 305 citing articles:
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
Chen Zhang, Xinyin Liu, Shidai Jin, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 794
Chen Zhang, Xinyin Liu, Shidai Jin, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 794
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 499
Peng Fu, Minru Liao, Rui Qin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 499
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment
Yi Liu, Yicong Wan, Yi Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188890-188890
Closed Access | Times Cited: 220
Yi Liu, Yicong Wan, Yi Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188890-188890
Closed Access | Times Cited: 220
Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
Jiawen Yang, Jiajie Mo, Juji Dai, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 213
Jiawen Yang, Jiajie Mo, Juji Dai, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 213
System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
Feng‐Jiao Li, Hui‐Zhi Long, Ziwei Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 207
Feng‐Jiao Li, Hui‐Zhi Long, Ziwei Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 207
The emerging role of ferroptosis in intestinal disease
Shu Xu, Yao He, Lihui Lin, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 185
Shu Xu, Yao He, Lihui Lin, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 185
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
Quan Gao, Jiao Feng, Wen‐Cheng Liu, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114445-114445
Closed Access | Times Cited: 169
Quan Gao, Jiao Feng, Wen‐Cheng Liu, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114445-114445
Closed Access | Times Cited: 169
Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 168
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 168
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies
Jing Zhou, Qing Ji, Qi Li
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 150
Jing Zhou, Qing Ji, Qi Li
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 150
The Role of HO-1 and Its Crosstalk with Oxidative Stress in Cancer Cell Survival
Shih-Kai Chiang, Shuen‐Ei Chen, Ling‐Chu Chang
Cells (2021) Vol. 10, Iss. 9, pp. 2401-2401
Open Access | Times Cited: 139
Shih-Kai Chiang, Shuen‐Ei Chen, Ling‐Chu Chang
Cells (2021) Vol. 10, Iss. 9, pp. 2401-2401
Open Access | Times Cited: 139
Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer
Zheng Zhang, Menglan Lu, Cailong Chen, et al.
Theranostics (2021) Vol. 11, Iss. 7, pp. 3167-3182
Open Access | Times Cited: 138
Zheng Zhang, Menglan Lu, Cailong Chen, et al.
Theranostics (2021) Vol. 11, Iss. 7, pp. 3167-3182
Open Access | Times Cited: 138
Arsenene Nanodots with Selective Killing Effects and their Low‐Dose Combination with ß‐Elemene for Cancer Therapy
Chuang LIU, Shan Sun, Qiang Feng, et al.
Advanced Materials (2021) Vol. 33, Iss. 37
Closed Access | Times Cited: 116
Chuang LIU, Shan Sun, Qiang Feng, et al.
Advanced Materials (2021) Vol. 33, Iss. 37
Closed Access | Times Cited: 116
Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer
Hao Chen, Qinqin Qi, Nan Wu, et al.
Redox Biology (2022) Vol. 55, pp. 102426-102426
Open Access | Times Cited: 105
Hao Chen, Qinqin Qi, Nan Wu, et al.
Redox Biology (2022) Vol. 55, pp. 102426-102426
Open Access | Times Cited: 105
Regulatory pathways and drugs associated with ferroptosis in tumors
Dan Wang, Le Tang, Yijie Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 87
Dan Wang, Le Tang, Yijie Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 87
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Qianyu Wang, Xiaofei Shen, Gang Chen, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2928-2928
Open Access | Times Cited: 85
Qianyu Wang, Xiaofei Shen, Gang Chen, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2928-2928
Open Access | Times Cited: 85
The emerging roles of MAPK-AMPK in ferroptosis regulatory network
Xinyue Wang, Xiao Tan, Jinping Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 66
Xinyue Wang, Xiao Tan, Jinping Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 66
A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage
Yujie Zhang, Jingjie Zhao, Lingmin Zhang, et al.
Nano Today (2023) Vol. 49, pp. 101798-101798
Closed Access | Times Cited: 62
Yujie Zhang, Jingjie Zhao, Lingmin Zhang, et al.
Nano Today (2023) Vol. 49, pp. 101798-101798
Closed Access | Times Cited: 62
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 3, pp. 614-682
Open Access | Times Cited: 55
Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 3, pp. 614-682
Open Access | Times Cited: 55
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer
Cong Xu, Zebo Jiang, Le Shao, et al.
Pharmacological Research (2023) Vol. 191, pp. 106739-106739
Open Access | Times Cited: 55
Cong Xu, Zebo Jiang, Le Shao, et al.
Pharmacological Research (2023) Vol. 191, pp. 106739-106739
Open Access | Times Cited: 55
Ferroptosis in colorectal cancer: a future target?
Hong Yan, Ronan Talty, Oladimeji Aladelokun, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 8, pp. 1439-1451
Closed Access | Times Cited: 51
Hong Yan, Ronan Talty, Oladimeji Aladelokun, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 8, pp. 1439-1451
Closed Access | Times Cited: 51
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 47
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 47
Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance
Xudong Zhu, Shenglong Li
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 44
Xudong Zhu, Shenglong Li
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 44
Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 24
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 24
Screening and modification of (+)-germacrene a synthase for the production of the antitumor drug (−)-β-elemene in engineered Saccharomyces cerevisiae
Yuhan Hu, Qin Zhang, Xue Bai, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135455-135455
Closed Access | Times Cited: 21
Yuhan Hu, Qin Zhang, Xue Bai, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135455-135455
Closed Access | Times Cited: 21
